(Q35994960)

11 August 2017

1 reference

title

Mathematical models of cancer dormancy (English)

1 reference

11 August 2017

1 reference

2

Jonathan W Uhr

1 reference

11 August 2017

Karen Page

1

1 reference

11 August 2017

publication date

1 March 2005

1 reference

11 August 2017

1 reference

11 August 2017

volume

46

1 reference

11 August 2017

issue

3

1 reference

11 August 2017

page(s)

313-327

1 reference

Immunologically-mediated restraint of latent tumour metastases

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190400011625

Cancer dormancy: opportunities for new therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400011625

Spontaneous murine B-cell leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400011625

BCL1, a Murine Model for Chronic Lymphocytic Leukemia: Use of the Surface Immunoglobulin Idiotype for the Detection and Treatment of Tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400011625

Tumor dormancy and cell signaling. II. Antibody as an agonist in inducing dormancy of a B cell lymphoma in SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400011625

Oncogenes, anti-oncogenes and the immune response to cancer: a mathematical model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400011625

Analysis of a "phase transition" from tumor growth to latency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400011625

The effect of time delays on the dynamics of avascular tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400011625

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400011625

Preliminary experience in treating lymphocytic leukaemia with antibody to immunoglobulin idiotypes on the cell surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400011625

Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400011625

Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400011625

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400011625

The clonal evolution of tumor cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400011625

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400011625

Resource competition as a mechanism for B cell homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400011625

Population biology of lymphocytes: the flight for survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400011625

Independent homeostatic regulation of B cell compartments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400011625

Lymphocyte homing and homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400011625

Diversification of haematopoietic stem cells to specific lineages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400011625

10.1080/10428190400011625

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference